{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:39:16Z","timestamp":1787071156662,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>Papillary thyroid cancer (PTC) is a serious threat to human health worldwide, while metastasis in the early phase limits therapeutic success and leads to poor survival outcomes. The CXC chemokine receptor type 4 (CXCR4) plays an important role in many cellular movements such as transcriptional modulation, cell skeleton rearrangement, and cell migration, and the change in CXCR4 levels are crucial in various diseases including cancer. In this study, we explored the role of CXCR4 in the migration and invasion of PTC and investigated the potential mechanisms underlying its effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>\n                      We analyzed the expression levels of CXCR4 in PTC tissues and cell lines. Would healing migration, Transwell invasion assay\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      , and tail-vein lung metastasis assay\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      were performed to evaluated the migration and invasion abilities of PTC cells with stable CXCR4 knockdown or overexpression. Signal transducers and activators of transcription (STAT3) signaling pathway-related protein expressions were examined by Western blotting assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The results showed that CXCR4 was highly expressed in PTC cell lines and PTC tissues. CXCR4 knockdown in PTC cells dampened the migration, invasion, and epithelial\u2013mesenchymal transition (EMT), whereas CXCR4 overexpression enhanced these properties.\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      , we also found that CXCR4 promoted the metastasis of PTC. Mechanistic studies showed that CXCR4 played these vital roles through the STAT3 signaling pathway. Furthermore, PTC patients with high CXCR4 or p-STAT3 expression correlated with aggressive clinical characteristics such as extrathyroidal extension (ETE), and lymph node metastasis (LNM).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We provided evidence that CXCR4 might activate the STAT3 signaling pathway and further promote PTC development. Thus, CXCR4 might be a novel therapeutic target for PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2395_22","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:46:33Z","timestamp":1724931993000},"page":"1241-1250","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["CXCR4 promotes migration, invasion, and epithelial\u2013mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway"],"prefix":"10.4103","volume":"20","author":[{"given":"Yajie","family":"Hu","sequence":"first","affiliation":[{"name":"Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"},{"name":"Department of Urology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Organ Transplantation and Nephrosis, Shandong Institute of Nephrology, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Tengzhou Central People\u2019s Hospital, Zaozhuang, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Tengzhou Central People\u2019s Hospital, Zaozhuang, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houlong","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Tengzhou Central People\u2019s Hospital, Zaozhuang, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Organ Transplantation and Nephrosis, Shandong Institute of Nephrology, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Institute of Nephrology, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Organ Transplantation and Nephrosis, Shandong Institute of Nephrology, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wei","sequence":"additional","affiliation":[{"name":"Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"},{"name":"Department of Endocrinology and Metabology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong Institute of Nephrology, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanlin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/thy.2018.0609","article-title":"Tumor volume doubling time in active surveillance of papillary thyroid carcinoma","volume":"29","author":"Oh","year":"2019","journal-title":"Thyroid"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrendo.2016.224","article-title":"Thyroid cancer:Overdiagnosis of papillary carcinoma-who benefits?","volume":"13","author":"Brito","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2020.12.026","article-title":"HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1","volume":"501","author":"Pan","year":"2021","journal-title":"Cancer Lett"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4103\/jcrt.JCRT_1268_20","article-title":"Assessment of preoperative thyroglobulin levels in papillary thyroid cancer","volume":"18","author":"Melik","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.4103\/jcrt.jcrt_1737_21","article-title":"Mandibular metastasis of follicular thyroid carcinoma","volume":"19","author":"Devi","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/thy.2019.0229","article-title":"Extrathyroidal extension is an important predictor of regional lymph node metastasis in pediatric differentiated thyroid cancer","volume":"30","author":"Jain","year":"2020","journal-title":"Thyroid"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1038\/s41467-020-18497-3","article-title":"Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4103\/jcrt.JCRT_480_19","article-title":"CXCR4 and RIF1 overexpression induces resistance of epithelial ovarian cancer to cisplatin-based chemotherapy","volume":"17","author":"Elaziz","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"29144","DOI":"10.1073\/pnas.2013319117","article-title":"Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists","volume":"117","author":"I\u015fbilir","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41388-018-0519-2","article-title":"CXCR7\/CXCR4 heterodimer-induced histone demethylation:A new mechanism of colorectal tumorigenesis","volume":"38","author":"Song","year":"2019","journal-title":"Oncogene"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"e2015433118","DOI":"10.1073\/pnas.2015433118","article-title":"A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment","volume":"118","author":"Song","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1038\/s41375-021-01376-1","article-title":"CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness","volume":"35","author":"Lewis","year":"2021","journal-title":"Leukemia"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1038\/onc.2017.108","article-title":"A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis","volume":"36","author":"Xiang","year":"2017","journal-title":"Oncogene"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1507\/endocrj.EJ21-0076","article-title":"Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness","volume":"69","author":"Cao","year":"2022","journal-title":"Endocr J"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ccell.2016.03.004","article-title":"Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA","volume":"29","author":"Qu","year":"2016","journal-title":"Cancer Cell"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4103\/jcrt.jcrt_188_22","article-title":"Tumor budding in breast carcinoma:A systematic review and meta-analysis","volume":"19","author":"Buch","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4103\/jcrt.jcrt_212_22","article-title":"Effects of the CRYAB gene on stem cell-like properties of colorectal cancer and its mechanism","volume":"18","author":"Dai","year":"2022","journal-title":"J J Cancer Res Ther"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.3390\/cancers13215567","article-title":"Papillary thyroid cancer prognosis:An evolving field","volume":"13","author":"Ulisse","year":"2021","journal-title":"Cancers"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/jcrt.jcrt_1471_22","article-title":"PD-L1 expression in rare and aggressive thyroid cancers:A preliminary investigation for a role of immunotherapy","volume":"19","author":"Boruah","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R20-20241021","first-page":"52","article-title":"Recurrence of papillary thyroid cancer after optimized surgery","volume":"4","author":"Grant","year":"2015","journal-title":"Gland Surg"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.3390\/ijms16036153","article-title":"New therapies for dedifferentiated papillary thyroid cancer","volume":"16","author":"Fallahi","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-020-01294-3","article-title":"Cytokine-chemokine network driven metastasis in esophageal cancer;Promising avenue for targeted therapy","volume":"20","author":"Bhat","year":"2021","journal-title":"Mol Cancer"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1158\/2326-6066.CIR-19-1005","article-title":"Macrophages instruct aberrant glycosylation in colon cancer by chemokine and cytokine signals","volume":"8","author":"Bronte","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-17-2158","article-title":"Inflammatory breast cancer promotes development of M2 tumor-associated macrophages and cancer mesenchymal cells through a complex chemokine network","volume":"79","author":"Valeta-Magara","year":"2019","journal-title":"Cancer Res"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-pharmtox-010919-023340","article-title":"The CXCL12\/CXCR4\/ACKR3 Axis in the tumor microenvironment:Signaling, crosstalk, and therapeutic targeting","volume":"61","author":"Smit","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jid.2020.06.034","article-title":"Cancer-associated fibroblasts in mycosis fungoides promote tumor cell migration and drug resistance through CXCL12\/CXCR4","volume":"141","author":"Aronovich","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.7150\/thno.54027","article-title":"Nodal-induced L1CAM\/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids","volume":"11","author":"Cave","year":"2021","journal-title":"Theranostics"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymthe.2020.09.034","article-title":"Olaparib suppresses MDSC recruitment via SDF1?\/CXCR4 axis to improve the anti-tumor efficacy of CAR-T cells on breast cancer in mice","volume":"29","author":"Sun","year":"2021","journal-title":"Mol Ther"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2017-04-776740","article-title":"SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma","volume":"130","author":"Patricia","year":"2017","journal-title":"Blood"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"687322","DOI":"10.3389\/fcell.2021.687322","article-title":"CD44v6-O-MWNTS-Loaded Gemcitabine and CXCR4 siRNA Improves the Anti-tumor effectiveness of ovarian cancer","volume":"9","author":"Yin","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R31-20241021","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-014-0103-8","article-title":"Blockade of CXCL12\/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway","volume":"33","author":"Zhao","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"R32-20241021","doi-asserted-by":"crossref","first-page":"929","DOI":"10.21037\/atm-20-1054","article-title":"Extracellular ubiquitin promotes hepatoma metastasis by mediating M2 macrophage polarization via the activation of the CXCR4\/ERK signaling pathway","volume":"8","author":"Cai","year":"2020","journal-title":"Ann Transl Med"},{"key":"R33-20241021","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.canlet.2014.08.012","article-title":"SDF-1\/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt\/?-catenin signaling pathway","volume":"354","author":"Hu","year":"2014","journal-title":"Cancer Lett"},{"key":"R34-20241021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/0008-5472.CAN-18-0620","article-title":"Inhibition of dipeptidyl peptidase-4 accelerates epithelial-mesenchymal transition and breast cancer metastasis via the CXCL12\/CXCR4\/mTOR axis","volume":"79","author":"Yang","year":"2019","journal-title":"Cancer Res"},{"key":"R35-20241021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2019.09.022","article-title":"Repurposing of drugs as STAT3 inhibitors for cancer therapy","volume":"68","author":"Thilakasiri","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"R36-20241021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"R37-20241021","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2020.02.026","article-title":"Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer","volume":"476","author":"Qin","year":"2020","journal-title":"Cancer Lett"},{"key":"R38-20241021","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1158\/0008-5472.CAN-17-3131","article-title":"IL22RA1\/STAT3 signaling promotes stemness and tumorigenicity in pancreatic cancer","volume":"78","author":"He","year":"2018","journal-title":"Cancer Res"},{"key":"R39-20241021","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/cbin.10794","article-title":"C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2\/STAT3","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell Biol Int"},{"key":"R40-20241021","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s13277-013-0725-z","article-title":"CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer","volume":"34","author":"Shen","year":"2013","journal-title":"Tumour Biol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2395_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:42:20Z","timestamp":1787067740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2395_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2395_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2023-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}